# PhilHealth Konsulta Payment Scheme: Complete Guide and Analysis

## Table of Contents

1. [Basic Overview](https://claude.ai/chat/66260f5d-e997-41c1-9c70-74d16a209541#basic-overview)
2. [Payment Structure](https://claude.ai/chat/66260f5d-e997-41c1-9c70-74d16a209541#payment-structure)
3. [Covered Services](https://claude.ai/chat/66260f5d-e997-41c1-9c70-74d16a209541#covered-services)
4. [Performance Indicators](https://claude.ai/chat/66260f5d-e997-41c1-9c70-74d16a209541#performance-indicators)
5. [Age-Specific Considerations](https://claude.ai/chat/66260f5d-e997-41c1-9c70-74d16a209541#age-specific-considerations)
6. [Scenario Analysis: Elementary School Children](https://claude.ai/chat/66260f5d-e997-41c1-9c70-74d16a209541#scenario-analysis-elementary-school-children)
7. [Scenario Analysis: Elderly Patients](https://claude.ai/chat/66260f5d-e997-41c1-9c70-74d16a209541#scenario-analysis-elderly-patients)
8. [Key Findings and System Issues](https://claude.ai/chat/66260f5d-e997-41c1-9c70-74d16a209541#key-findings-and-system-issues)

------

## Basic Overview

**Konsulta** (Konsultasyong Sulit at Tama) is PhilHealth's primary care benefit package that provides basic healthcare services to Filipino families through a **capitation payment system**.

### Key Facts

- **Maximum Annual Payment**: ‚Ç±1,700 per beneficiary per year (as of January 2024)
- **Applies to**: Both government and private healthcare providers
- **Additional Charges**: Private providers can charge up to ‚Ç±900 additional co-payment per year
- **Tax**: Private providers pay 2% withholding tax on PhilHealth payments

------

## Payment Structure

### Two-Tranche System

| Tranche            | Percentage | Amount | Timing      | Requirements                  |
| ------------------ | ---------- | ------ | ----------- | ----------------------------- |
| **First Tranche**  | 40%        | ‚Ç±680   | Monthly     | First Patient Encounter (FPE) |
| **Second Tranche** | 60%        | ‚Ç±1,020 | End of year | Performance targets achieved  |

### First Tranche (40% - ‚Ç±680)

**üîë KEY POINTS:**

- **Trigger**: First Patient Encounter (FPE) required
- **Frequency**: Monthly payments based on new patients
- **Continuation**: No new FPE needed in following years IF at least one medical consultation occurred in previous year
- **Timeline**: Payment within 60 days after 8th day of following month
- **Data Submission**: Must upload complete data by 11:59 PM of 7th day of month

#### Sample Monthly Payments (Public Provider)

| Month            | New Patients with FPE | Payment (‚Ç±680 each) |
| ---------------- | --------------------- | ------------------- |
| January          | 1,500                 | ‚Ç±1,020,000          |
| February         | 2,000                 | ‚Ç±1,360,000          |
| March            | 500                   | ‚Ç±340,000            |
| **Annual Total** | **14,850**            | **‚Ç±10,098,000**     |

### Second Tranche (60% - ‚Ç±1,020)

**Performance-based payment** calculated at year-end based on achievement of four key indicators.

------

## Covered Services

### Laboratory Services (15 Tests)

| Test                                   | Purpose                                                |
| -------------------------------------- | ------------------------------------------------------ |
| **Complete Blood Count (CBC)**         | Blood disorders, infections                            |
| **Lipid Profile**                      | Heart disease risk assessment                          |
| **Fasting Blood Sugar (FBS)**          | Diabetes screening                                     |
| **Oral Glucose Tolerance Test (OGTT)** | Diabetes diagnosis                                     |
| **Glycosylated Hemoglobin (HbA1c)**    | Diabetes monitoring                                    |
| **Creatinine**                         | Kidney function                                        |
| **Chest X-Ray**                        | Lung problems                                          |
| **Sputum Microscopy**                  | Tuberculosis detection                                 |
| **Electrocardiogram (ECG)**            | Heart problems                                         |
| **Mammogram**                          | Breast cancer screening                                |
| **Ultrasound**                         | Internal organ imaging (upper abdomen, pelvic, breast) |
| **Urinalysis**                         | Kidney/urinary problems                                |
| **Pap Smear**                          | Cervical cancer screening                              |
| **Fecalysis**                          | Intestinal parasites                                   |
| **Fecal Occult Blood Test**            | Colon cancer screening                                 |

### Antibiotic Medicines (6 Types)

| Medicine           | Category       | Common Uses                  |
| ------------------ | -------------- | ---------------------------- |
| **Amoxicillin**    | Anti-microbial | Common bacterial infections  |
| **Co-Amoxiclav**   | Anti-microbial | Serious bacterial infections |
| **Cotrimoxazole**  | Anti-microbial | UTI, pneumonia               |
| **Nitrofurantoin** | Anti-microbial | Urinary tract infections     |
| **Ciprofloxacin**  | Anti-microbial | Various bacterial infections |
| **Clarithromycin** | Anti-microbial | Respiratory infections       |

### Chronic Disease (NCD) Medicines

#### For Diabetes:

- **Gliclazide**, **Metformin**

#### For High Blood Pressure:

- **Enalapril**, **Metoprolol**, **Amlodipine**, **Hydrochlorothiazide**, **Losartan**

#### For High Cholesterol:

- **Simvastatin**

#### For Heart Protection:

- **Aspirin**

#### For Asthma:

- **Salbutamol**, **Fluticasone + Salmeterol**

### Other Available Medicines:

- **Oral Rehydration Salts** (dehydration)
- **Prednisone** (inflammation)
- **Paracetamol** (fever and pain)
- **Chlorphenamine** (allergies - hospital use only)

------

## Performance Indicators

### Four Key Performance Areas

| Indicator                        | Target | Weight | Calculation                                                  |
| -------------------------------- | ------ | ------ | ------------------------------------------------------------ |
| **1. Primary Care Consultation** | 100%   | 30%    | Unique patients with consultation √∑ Total patients with FPE  |
| **2. Laboratory Services**       | 50%    | 30%    | Unique patients with lab services √∑ Total patients with FPE  |
| **3. Antibiotic Medicines**      | 15%    | 10%    | Unique patients with antibiotics √∑ Total patients with FPE   |
| **4. Chronic Disease Medicines** | 20%    | 30%    | Unique patients with NCD medicines √∑ Total patients with FPE |

### Sample Performance Calculation

**Scenario**: 14,850 patients with FPE

- Consultations: 8,000 patients
- Laboratory services: 3,000 patients
- Antibiotics: 2,000 patients
- NCD medicines: 1,500 patients

| Indicator              | Actual Performance | Target | Score | Weight | Weighted Score |
| ---------------------- | ------------------ | ------ | ----- | ------ | -------------- |
| **Consultation**       | 54% (8,000/14,850) | 100%   | 0.54  | 30%    | **16%**        |
| **Laboratory**         | 20% (3,000/14,850) | 50%    | 0.40  | 30%    | **12%**        |
| **Antibiotics**        | 13% (2,000/14,850) | 15%    | 0.87  | 10%    | **9%**         |
| **NCD Medicines**      | 10% (1,500/14,850) | 20%    | 0.50  | 30%    | **15%**        |
| **PERFORMANCE FACTOR** |                    |        |       |        | **52%**        |

### Second Tranche Payment Calculation

- **Public Provider**: 14,850 √ó 0.52 √ó ‚Ç±1,020 = **‚Ç±7,876,440**
- **Private Provider**: (14,850 √ó 0.52 √ó ‚Ç±1,020) - 2% tax = **‚Ç±7,718,911**

------

## Age-Specific Considerations

### CRITICAL FINDING: No Age-Specific Performance Factors

**The performance indicators apply universally to ALL ages** - this creates significant problems for providers serving specific age groups.

### Age-Appropriate Preventive Services

While services are age-targeted, **performance metrics are not**:

| Age Group       | Recommended Services           |
| --------------- | ------------------------------ |
| **0-12 months** | CBC with platelet count        |
| **1-4 years**   | General consultations          |
| **5-9 years**   | General consultations          |
| **10-19 years** | Chest X-ray                    |
| **20-39 years** | PAP Smear/VIA (can be waived)  |
| **40-49 years** | Lipid Profile, FBS, OGTT       |
| **50-59 years** | FOBT (Fecal Occult Blood Test) |
| **60+ years**   | ECG                            |
| **70+ years**   | All previous services          |
| **Risk-based**  | Mammography                    |

------

## Scenario Analysis: Elementary School Children

### Problem Statement

**What happens if 100% of patients are elementary school age children (5-9 years old)?**

### Impact Analysis for 1,000 Children

#### First Tranche: UNAFFECTED

- **Payment**: ‚Ç±680 √ó 1,000 = **‚Ç±680,000**
- This payment is guaranteed regardless of age

#### Second Tranche: SEVERE NEGATIVE IMPACT

| Performance Indicator         | Target | Reality for Ages 5-9                         | Expected Performance | Impact             |
| ----------------------------- | ------ | -------------------------------------------- | -------------------- | ------------------ |
| **Primary Care Consultation** | 100%   | ‚úÖ Children visit doctors                     | **100%**             | **Full points**    |
| **Laboratory Services**       | 50%    | ‚ùì Most tests not age-appropriate             | **25%**              | **Reduced points** |
| **Antibiotic Medicines**      | 15%    | ‚ö†Ô∏è Only if infections occur                   | **10%**              | **Some points**    |
| **Chronic Disease Medicines** | 20%    | ‚ùå Children rarely have diabetes/hypertension | **2%**               | **Minimal points** |

### Realistic Performance Calculation

| Indicator                    | Expected Performance | Target | Score | Weight | Weighted Score |
| ---------------------------- | -------------------- | ------ | ----- | ------ | -------------- |
| **Consultation**             | 100%                 | 100%   | 1.00  | 30%    | **30%**        |
| **Laboratory**               | 25%                  | 50%    | 0.50  | 30%    | **15%**        |
| **Antibiotics**              | 10%                  | 15%    | 0.67  | 10%    | **7%**         |
| **Chronic Disease**          | 2%                   | 20%    | 0.10  | 30%    | **3%**         |
| **TOTAL PERFORMANCE FACTOR** |                      |        |       |        | **55%**        |

### Financial Impact

| Payment Component  | Standard Amount | With Children Only | Difference           |
| ------------------ | --------------- | ------------------ | -------------------- |
| **First Tranche**  | ‚Ç±680,000        | ‚Ç±680,000           | ‚Ç±0                   |
| **Second Tranche** | ‚Ç±1,020,000      | ‚Ç±561,000           | **-‚Ç±459,000**        |
| **TOTAL ANNUAL**   | ‚Ç±1,700,000      | ‚Ç±1,241,000         | **-‚Ç±459,000**        |
| **Per Patient**    | ‚Ç±1,700          | ‚Ç±1,241             | **-‚Ç±459 (27% loss)** |

------

## Scenario Analysis: Elderly Patients

### Problem Statement

**What happens if 100% of patients are elderly (60+ years old)?**

This scenario represents the **opposite extreme** from the elementary school children case, where elderly patients are most likely to benefit from the current performance indicators.

### Impact Analysis for 1,000 Elderly Patients

#### First Tranche: UNAFFECTED

- **Payment**: ‚Ç±680 √ó 1,000 = **‚Ç±680,000**
- This payment is guaranteed regardless of age

#### Second Tranche: HIGHLY FAVORABLE

| Performance Indicator         | Target | Reality for Ages 60+                       | Expected Performance | Impact                 |
| ----------------------------- | ------ | ------------------------------------------ | -------------------- | ---------------------- |
| **Primary Care Consultation** | 100%   | ‚úÖ Elderly visit doctors frequently         | **100%**             | **Full points**        |
| **Laboratory Services**       | 50%    | ‚úÖ Most tests age-appropriate               | **70-80%**           | **Exceeds target**     |
| **Antibiotic Medicines**      | 15%    | ‚úÖ Higher infection rates                   | **20%**              | **Exceeds target**     |
| **Chronic Disease Medicines** | 20%    | ‚úÖ High prevalence of diabetes/hypertension | **60-80%**           | **Far exceeds target** |

### Detailed Analysis by Performance Area

#### PRIMARY CARE CONSULTATION (30% weight)

**Target**: 100% should consult doctors **Reality**: Elderly patients typically have multiple health concerns requiring regular medical supervision **Expected Performance**: **100%** ‚úÖ **Points Earned**: **Full 30%**

#### LABORATORY SERVICES (30% weight)

**Target**: 50% should receive laboratory services **Reality**: Ages 60+ have **ALL laboratory tests as "Recommended"**:

- CBC, Urinalysis, Fecalysis (basic screening)
- Lipid Profile, FBS, OGTT, HbA1c (diabetes/heart disease)
- ECG (heart monitoring - specifically recommended for 60+)
- FOBT (colon cancer screening - for 50+)
- Chest X-ray, Creatinine (kidney/lung health)
- Mammogram (risk-based for elderly women)

**Expected Performance**: **70-80%** (far exceeds 50% target) **Points Earned**: **Full 30%** (capped at target achievement)

#### ANTIBIOTIC MEDICINES (10% weight)

**Target**: 15% should receive antibiotics **Reality**: Elderly patients have:

- Higher susceptibility to infections
- More frequent respiratory tract infections
- Urinary tract infections (especially women)
- Slower immune response requiring antibiotic treatment

**Expected Performance**: **20-25%** (exceeds 15% target) **Points Earned**: **Full 10%** (capped at target achievement)

#### CHRONIC DISEASE MEDICINES (30% weight)

**Target**: 20% should receive NCD medications **Reality**: Elderly patients commonly have:

- **Hypertension**: 60-70% prevalence (Enalapril, Amlodipine, Losartan, etc.)
- **Diabetes**: 15-20% prevalence (Metformin, Gliclazide)
- **Heart Disease**: Aspirin for protection
- **High Cholesterol**: Simvastatin
- **COPD/Asthma**: Salbutamol, combination inhalers

**Expected Performance**: **60-80%** (far exceeds 20% target) **Points Earned**: **Full 30%** (capped at target achievement)

### Optimal Performance Calculation

| Indicator                    | Expected Performance | Target | Score | Weight | Weighted Score |
| ---------------------------- | -------------------- | ------ | ----- | ------ | -------------- |
| **Consultation**             | 100%                 | 100%   | 1.00  | 30%    | **30%**        |
| **Laboratory**               | 75%                  | 50%    | 1.00* | 30%    | **30%**        |
| **Antibiotics**              | 22%                  | 15%    | 1.00* | 10%    | **10%**        |
| **Chronic Disease**          | 70%                  | 20%    | 1.00* | 30%    | **30%**        |
| **TOTAL PERFORMANCE FACTOR** |                      |        |       |        | **100%**       |

*Score capped at 1.00 (100%) even when performance exceeds target

### Financial Impact

| Payment Component  | Standard Amount | With Elderly Only | Difference             |
| ------------------ | --------------- | ----------------- | ---------------------- |
| **First Tranche**  | ‚Ç±680,000        | ‚Ç±680,000          | ‚Ç±0                     |
| **Second Tranche** | ‚Ç±1,020,000      | ‚Ç±1,020,000        | **‚Ç±0**                 |
| **TOTAL ANNUAL**   | ‚Ç±1,700,000      | ‚Ç±1,700,000        | **‚Ç±0**                 |
| **Per Patient**    | ‚Ç±1,700          | ‚Ç±1,700            | **‚Ç±0 (0% difference)** |

### Comparison: Children vs. Elderly

| Aspect                       | Elementary Children (5-9) | Elderly (60+)     | Impact              |
| ---------------------------- | ------------------------- | ----------------- | ------------------- |
| **Performance Factor**       | 55%                       | 100%              | **45% difference**  |
| **Revenue per Patient**      | ‚Ç±1,241                    | ‚Ç±1,700            | **‚Ç±459 difference** |
| **System Alignment**         | Poor                      | Excellent         | **Major disparity** |
| **Clinical Appropriateness** | Conflicts with age        | Matches age needs | **System bias**     |

------

## Key Findings and System Issues

### Critical System Design Flaws

1. **Age-Inappropriate Performance Targets**
   - Chronic disease medicine target (30% weight) impossible for healthy children, easily achieved for elderly
   - Laboratory service targets don't align with age-appropriate care for young populations
   - One-size-fits-all approach creates 45% revenue difference between age groups
2. **Financial Disincentives and Advantages**
   - Providers serving children lose 27% of potential revenue (‚Ç±459 per patient)
   - Providers serving elderly achieve maximum revenue potential
   - Creates market incentives favoring elderly care over pediatric care
   - May discourage comprehensive family practice
3. **System Bias and Inequity**
   - Performance indicators designed around adult/elderly health patterns
   - Creates inherent advantage for providers with older patient demographics
   - Penalizes appropriate pediatric and young adult care
   - Results in ‚Ç±459 per patient revenue disparity based solely on age demographics
4. **Misaligned Clinical Incentives**
   - System could reward inappropriate prescribing (giving diabetes medicines to children)
   - Penalizes appropriate age-specific care patterns
   - Conflicts with evidence-based medicine principles
   - Creates pressure to over-treat young patients or under-serve elderly patients

### Operational Challenges

1. **Data Submission Requirements**
   - Daily/weekly uploads required
   - XML file submissions through HCI Portal
   - Strict deadlines (11:59 PM, 7th day of month)
   - System validation requirements
2. **Documentation Requirements**
   - Photo documentation of patients mandatory
   - Electronic Konsulta Availment Slip (EKAS)
   - Electronic Prescription Slip (EPRESS)
   - Proper encoding in PhilHealth systems
3. **Service Level Agreements**
   - KPPs without mammogram/ultrasound must arrange SLAs within 3 years
   - Additional service notifications required to PhilHealth
   - Telemedicine services must be properly recorded and submitted

### Recommendations for System Improvement

1. **Age-Stratified Performance Indicators**
   - Develop separate targets for pediatric (0-17), adult (18-59), and geriatric (60+) populations
   - Align performance metrics with age-appropriate care standards
   - Weight indicators based on population health needs and clinical evidence
2. **Population-Adjusted Payment Factors**
   - Introduce age-demographic adjustment factors to ensure payment equity
   - Create separate performance benchmarks for different age groups
   - Maintain total capitation amount while adjusting performance calculations
3. **Flexible Service Requirements**
   - Adjust laboratory service targets based on age distribution of patient population
   - Create age-appropriate chronic disease indicators (e.g., asthma for children, diabetes for adults)
   - Allow for population-specific performance calculations
4. **Equity Protection Measures**
   - Ensure equal payment opportunities regardless of patient age demographics
   - Implement minimum performance floors to protect providers serving challenging populations
   - Create incentives for comprehensive, all-age family practice models

### Summary Statistics - Age Impact Comparison

| Patient Population            | Performance Factor | Revenue per Patient | System Advantage        |
| ----------------------------- | ------------------ | ------------------- | ----------------------- |
| **Elementary Children (5-9)** | 55%                | ‚Ç±1,241              | **Severe disadvantage** |
| **Mixed Population**          | 52-85%             | ‚Ç±1,400-1,700        | Moderate to good        |
| **Elderly (60+)**             | 100%               | ‚Ç±1,700              | **Maximum advantage**   |
| **Revenue Gap**               | 45% difference     | ‚Ç±459 difference     | **Major inequity**      |

------

## Conclusion

The PhilHealth Konsulta payment scheme provides a structured approach to primary care funding but contains significant age-related bias that creates unintended consequences for providers. The system **heavily favors providers serving elderly patients** who can achieve 100% performance factors, while **severely penalizing providers serving children** with only 55% achievable performance. This 45% performance gap translates to ‚Ç±459 per patient revenue difference, creating market distortions that may undermine comprehensive primary care delivery.

The universal application of adult/elderly-oriented performance indicators highlights the critical need for age-stratified metrics that align financial incentives with appropriate, evidence-based care across all age groups. Healthcare IT professionals implementing Konsulta systems should advocate for demographic-adjusted performance calculations to ensure equitable compensation for quality care regardless of patient population characteristics.

------

*This document is based on PhilHealth Circular No. 2024-0013 and related implementing guidelines as of 2024.*